Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 4
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Tyrosine Kinase Receptors in Oncology.
Esteban-Villarrubia J, Soto-Castillo JJ, Pozas J, San Román-Gil M, Orejana-Martín I, Torres-Jiménez J, Carrato A, Alonso-Gordoa T, Molina-Cerrillo J. Esteban-Villarrubia J, et al. Among authors: pozas j. Int J Mol Sci. 2020 Nov 12;21(22):8529. doi: 10.3390/ijms21228529. Int J Mol Sci. 2020. PMID: 33198314 Free PMC article. Review.
Current Landscape of Immunotherapy for Advanced Sarcoma.
Albarrán V, Villamayor ML, Pozas J, Chamorro J, Rosero DI, San Román M, Guerrero P, Pérez de Aguado P, Calvo JC, García de Quevedo C, González C, Vaz MÁ. Albarrán V, et al. Among authors: pozas j. Cancers (Basel). 2023 Apr 13;15(8):2287. doi: 10.3390/cancers15082287. Cancers (Basel). 2023. PMID: 37190214 Free PMC article. Review.
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
Albarrán V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Román M, Calvo JC, Pérez de Aguado P, Moreno J, Guerrero P, González C, García de Quevedo C, Álvarez-Ballesteros P, Vaz MÁ. Albarrán V, et al. Among authors: pozas j. Int J Mol Sci. 2022 Nov 9;23(22):13784. doi: 10.3390/ijms232213784. Int J Mol Sci. 2022. PMID: 36430263 Free PMC article. Review.
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Torres-Jiménez J, Albarrán-Fernández V, Pozas J, Román-Gil MS, Esteban-Villarrubia J, Carrato A, Rosero A, Grande E, Alonso-Gordoa T, Molina-Cerrillo J. Torres-Jiménez J, et al. Among authors: pozas j. Int J Mol Sci. 2021 Jan 13;22(2):747. doi: 10.3390/ijms22020747. Int J Mol Sci. 2021. PMID: 33451055 Free PMC article. Review.
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma.
San-Román-Gil M, Torres-Jiménez J, Pozas J, Esteban-Villarrubia J, Albarrán-Fernández V, Álvarez-Ballesteros P, Chamorro-Pérez J, Rosero-Rodríguez D, Orejana-Martín I, Martínez-Delfrade Í, Reguera-Puertas P, Fuentes-Mateos R, Ferreiro-Monteagudo R. San-Román-Gil M, et al. Among authors: pozas j. Cancers (Basel). 2023 Jan 30;15(3):863. doi: 10.3390/cancers15030863. Cancers (Basel). 2023. PMID: 36765821 Free PMC article. Review.
BRAF Mutated Colorectal Cancer: New Treatment Approaches.
Molina-Cerrillo J, San Román M, Pozas J, Alonso-Gordoa T, Pozas M, Conde E, Rosas M, Grande E, García-Bermejo ML, Carrato A. Molina-Cerrillo J, et al. Among authors: pozas j. Cancers (Basel). 2020 Jun 14;12(6):1571. doi: 10.3390/cancers12061571. Cancers (Basel). 2020. PMID: 32545884 Free PMC article. Review.
Adoptive T cell therapy for solid tumors: current landscape and future challenges.
Albarrán V, San Román M, Pozas J, Chamorro J, Rosero DI, Guerrero P, Calvo JC, González C, García de Quevedo C, Pérez de Aguado P, Moreno J, Cortés A, Soria A. Albarrán V, et al. Among authors: pozas j. Front Immunol. 2024 Mar 14;15:1352805. doi: 10.3389/fimmu.2024.1352805. eCollection 2024. Front Immunol. 2024. PMID: 38550594 Free PMC article. Review.
Epigenetics in advanced renal cell carcinoma: Potential new targets.
Molina-Cerrillo J, Santoni M, Ruiz Á, Massari F, Pozas J, Ortego I, Gómez V, Grande E, Alonso-Gordoa T. Molina-Cerrillo J, et al. Among authors: pozas j. Crit Rev Oncol Hematol. 2022 Dec;180:103857. doi: 10.1016/j.critrevonc.2022.103857. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257538 Review.
19 results